NL193440C - Farmaceutisch preparaat met analgetische werking. - Google Patents

Farmaceutisch preparaat met analgetische werking. Download PDF

Info

Publication number
NL193440C
NL193440C NL8600302A NL8600302A NL193440C NL 193440 C NL193440 C NL 193440C NL 8600302 A NL8600302 A NL 8600302A NL 8600302 A NL8600302 A NL 8600302A NL 193440 C NL193440 C NL 193440C
Authority
NL
Netherlands
Prior art keywords
suppositories
diclofenac
codeine
acceptable salt
pharmaceutically acceptable
Prior art date
Application number
NL8600302A
Other languages
English (en)
Dutch (nl)
Other versions
NL193440B (nl
NL8600302A (nl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NL8600302A publication Critical patent/NL8600302A/nl
Publication of NL193440B publication Critical patent/NL193440B/xx
Application granted granted Critical
Publication of NL193440C publication Critical patent/NL193440C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NL8600302A 1985-02-08 1986-02-07 Farmaceutisch preparaat met analgetische werking. NL193440C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH570/85A CH664085A5 (de) 1985-02-08 1985-02-08 Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
CH57085 1985-02-08

Publications (3)

Publication Number Publication Date
NL8600302A NL8600302A (nl) 1986-09-01
NL193440B NL193440B (nl) 1999-07-01
NL193440C true NL193440C (nl) 1999-11-02

Family

ID=4190060

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8600302A NL193440C (nl) 1985-02-08 1986-02-07 Farmaceutisch preparaat met analgetische werking.

Country Status (18)

Country Link
US (1) US4690927A (fr)
JP (1) JPH0729916B2 (fr)
BE (1) BE904196A (fr)
CA (1) CA1255598A (fr)
CH (1) CH664085A5 (fr)
CY (1) CY1653A (fr)
DE (1) DE3603564C2 (fr)
FR (1) FR2577136B1 (fr)
GB (1) GB2170709B (fr)
HK (1) HK80492A (fr)
IE (1) IE58292B1 (fr)
IL (1) IL77780A (fr)
IT (1) IT1208452B (fr)
LU (1) LU86291A1 (fr)
NL (1) NL193440C (fr)
PH (1) PH22920A (fr)
SG (1) SG44592G (fr)
ZA (1) ZA86912B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (fr) * 1988-03-25 1990-10-15 Ciba Geigy Ag
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
TW225536B (fr) * 1990-08-23 1994-06-21 Ciba Geigy Ag
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US6348216B1 (en) 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
US8173164B2 (en) * 1999-06-17 2012-05-08 Gruenenthal Gmbh Oral administration forms for administering a fixed tramadol and diclofenac combination
JP2006504491A (ja) * 2002-10-31 2006-02-09 ユーロ−セルティーク エス．エイ． 医薬製品の識別
PT1667664T (pt) * 2003-09-24 2016-11-21 Novartis Consumer Health Sa Comprimidos revestidos de diclofenac
WO2007083985A1 (fr) * 2006-01-19 2007-07-26 Farmacéuticos Rayere, S.A. Composition pharmaceutique synergétique de diclofénac et de clonixinate de lysine
PT2405748T (pt) 2009-03-12 2018-11-23 Cumberland Pharmaceuticals Inc Administração de ibuprofeno intravenoso
WO2013112456A1 (fr) 2012-01-24 2013-08-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Formulations à libération contrôlée destinées à l'induction et à la prolifération de cellules sanguines
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CN108078988B (zh) * 2018-02-13 2019-10-25 山西省太原晋阳制药厂 双氯芬酸钠与磷酸可待因复方缓释组合物及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5283939A (en) * 1976-01-01 1977-07-13 Syntex Inc Medicine for anodyne
US4126684A (en) * 1976-02-11 1978-11-21 Ciba-Geigy Corporation 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse
AU528532B2 (en) * 1978-12-18 1983-05-05 Mcniel Laboratories Acetaminophen analgesic potentiation
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233314A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
DE3390116C2 (de) * 1982-07-22 1994-06-16 Richardson Vicks Inc Verbesserte, Koffein enthaltende, analgetische und antiinflammatorische Mittel
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
CH655507B (fr) * 1983-01-12 1986-04-30
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3538142A1 (de) * 1985-10-26 1987-04-30 Hoechst Ag Kombinationspraeparate aus analgetika und deren verwendung

Also Published As

Publication number Publication date
LU86291A1 (de) 1986-09-02
NL193440B (nl) 1999-07-01
GB8602625D0 (en) 1986-03-12
NL8600302A (nl) 1986-09-01
SG44592G (en) 1992-06-12
DE3603564A1 (de) 1986-08-14
IT1208452B (it) 1989-06-12
HK80492A (en) 1992-10-30
FR2577136B1 (fr) 1990-04-20
ZA86912B (en) 1986-09-24
US4690927A (en) 1987-09-01
FR2577136A1 (fr) 1986-08-14
GB2170709A (en) 1986-08-13
GB2170709B (en) 1989-06-07
CY1653A (en) 1993-05-14
CH664085A5 (de) 1988-02-15
PH22920A (en) 1989-01-24
JPS61183220A (ja) 1986-08-15
IT8647625A0 (it) 1986-02-06
IE860351L (en) 1986-08-08
IL77780A0 (en) 1986-07-31
DE3603564C2 (de) 1995-02-02
CA1255598A (fr) 1989-06-13
IL77780A (en) 1988-05-31
JPH0729916B2 (ja) 1995-04-05
BE904196A (fr) 1986-08-07
IE58292B1 (en) 1993-08-25

Similar Documents

Publication Publication Date Title
NL193440C (nl) Farmaceutisch preparaat met analgetische werking.
TW576743B (en) Extended release formulations of erythromycin derivatives
AU663303B2 (en) Compositions containing sumatriptan
FI101040B (fi) Menetelmä sentraalisten dopamiininpuutostilojen hoitoon tarkoitetun, p eroraalisesti annettavan lääkemuodon valmistamiseksi
JP2002509883A (ja) フマル酸アルキル水素エステルからなる乾癬、乾癬性関節炎、神経皮膚炎および限局性回腸炎クローン病の治療剤
BE899885A (fr) Comprimes de naproxen et de naproxen sodique a liberation controlee.
IE60661B1 (en) Nitrofurantoin dosage form
EP1294372B1 (fr) Formulation pulverente seche contenant du racecadotril
MXPA04011801A (es) Composicion farmaceutica que contiene oxcarbazepina con liberacion controlada de la substancia activa.
AU736357B2 (en) Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredient
US4888343A (en) Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
ZA881181B (en) Process for preparing a retard product containing diltiazem for a single daily administration
FR2904774A1 (fr) Composition pharmaceutique solide contenant une combinaison d'un agent regulateur de la motilite intestinale et d'un antiflatulent.
JPS59155312A (ja) 新規薬理製剤
EP0629400A1 (fr) Compositions contenant de l'idebenone pour le traitement de la maladie d'Alzheimer
JP2001518481A (ja) 経口投与のためのセロトニン含有製剤及びその使用方法
CA1099641A (fr) Traduction non-disponible
JP3982889B2 (ja) イブプロフェン含有医薬製剤
WO1996030016A3 (fr) Formulations de ridogrel a petites doses et leur utilisation dans le traitement de maladies intestinales inflammatoires
TW577741B (en) Novel pharmaceutical combination for treating pain comprising paracetamol and buspirone
US4391809A (en) Methods for treating psoriasis
JPS5938204B2 (ja) 再生不良性貧血治療剤
CN1088357C (zh) 5－硝基咪唑衍生物微粒
US4177281A (en) Therapeutic treatment for measles viral infection
Jubb et al. Double-blind comparison of etodolac sustained-release tablets and piroxicam capsules in patients with rheumatoid arthritis: an interim report

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NOVARTIS AG

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20060207